Cambridge Investment Research Advisors
NTRP

Cambridge Investment Research Advisors’s Neurotrope, Inc. Common NTRP Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-34,370
Closed -$38K – 2811
2020
Q3 		$38K Buy
+34,370
New +$39.5K ﹤0.01% 2463

Other funds holding NTRP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cambridge Investment Research Advisors's NTRP Position: Q4 2020 in Review

Cambridge Investment Research Advisors sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 34,370 shares — an estimated $38K sold.

Cambridge Investment Research Advisors first reported a position in NTRP in Q3 2020 and held it in 1 quarter. The position peaked at $38K in Q3 2020. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

  • Cambridge Investment Research Advisors reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 34,370 Neurotrope, Inc. Common shares in Q4 2020, an estimated $38K.
  • Cambridge Investment Research Advisors first reported a position in Neurotrope, Inc. Common in Q3 2020 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Neurotrope, Inc. Common position peaked at $38K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.